[{"NetIncomeLoss_1_Q2_USD":3464000.0,"PaymentsToAcquireInvestments_2_Q2_USD":1000000.0,"Depreciation_1_Q2_USD":1500000.0,"Depreciation_2_Q2_USD":3000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2967000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":17900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-7160000.0,"InventoryFinishedGoods_0_Q2_USD":60362000.0,"InterestPaidNet_2_Q2_USD":860000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":45253000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-9000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":15317000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":33637000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":33628000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":12610000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27462000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":287000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":186000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":3485000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":1734000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":94000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":2309000.0,"Assets_0_Q2_USD":556218000.0,"ProceedsFromOtherDebt_2_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":34132106.0,"IncomeTaxesPaidNet_2_Q2_USD":1671000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":2604000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":0.0,"SellingAndMarketingExpense_1_Q2_USD":29488000.0,"SellingAndMarketingExpense_2_Q2_USD":58459000.0,"ContractWithCustomerLiability_0_Q2_USD":29144000.0,"RestructuringCharges_1_Q2_USD":121000.0,"RestructuringCharges_2_Q2_USD":327000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":234000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":217000.0,"AssetsCurrent_0_Q2_USD":245699000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-817000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":19341000.0,"ProductWarrantyAccrual_0_Q2_USD":4802000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":612000.0,"Liabilities_0_Q2_USD":138391000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-2869000.0,"CommonStockValue_0_Q2_USD":347818000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":3444000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1899000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2368000.0,"AccountsReceivableNetCurrent_0_Q2_USD":92793000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-108000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-269000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-19000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":33871000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":33845000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":216000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":18089000.0,"EarningsPerShareBasic_1_Q2_USD":0.1,"EarningsPerShareBasic_2_Q2_USD":0.17,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":173770000.0,"Revenues_2_Q2_USD":230904000.0,"Revenues_1_Q2_USD":115978000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":14450000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":270090000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":8061000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":62494000.0,"OtherAssetsNoncurrent_0_Q2_USD":19136000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":3919000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":7816000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":3614000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":5773000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":1743000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-4117000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-7034000.0,"ProductWarrantyAccrualPayments_2_Q2_USD":1407000.0,"CostsAndExpenses_1_Q2_USD":47843000.0,"CostsAndExpenses_2_Q2_USD":94531000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-57848000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.354,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.288,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":11000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-720000.0,"ProductWarrantyAccrualPayments_1_Q2_USD":667000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14249000.0,"ShareBasedCompensation_2_Q2_USD":5622000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"InterestExpense_2_Q2_USD":1322000.0,"NonoperatingIncomeExpense_1_Q2_USD":-651000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2307000.0,"AccountsPayableCurrent_0_Q2_USD":26892000.0,"DeferredRevenueCurrent_0_Q2_USD":24465000.0,"LiabilitiesCurrent_0_Q2_USD":102463000.0,"InventoryWorkInProcess_0_Q2_USD":1841000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":33637000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":33628000.0,"RepaymentsOfDebt_2_Q2_USD":57000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":44096000.0,"ProductWarrantyExpense_2_Q2_USD":1014000.0,"MarketDataRevenue_1_Q2_USD":115978000.0,"MarketDataRevenue_2_Q2_USD":230904000.0,"Goodwill_0_Q2_USD":150482000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":30786000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":13361000.0,"InterestExpense_1_Q2_USD":556000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":13723000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":22062000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":80054000.0,"NetIncomeLoss_2_Q2_USD":5860000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":23552000.0,"PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease_2_Q2_USD":588000.0,"ShortTermBorrowings_0_Q2_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-1244000.0,"InventoryNoncurrent_0_Q2_USD":13194000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":5331000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":10038000.0,"ImpairmentChargeOnReclassifiedAssets_2_Q2_USD":265000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":78011000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":612000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-1106000.0,"GrossProfit_1_Q2_USD":66401000.0,"GrossProfit_2_Q2_USD":132888000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":2167000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":-4327000.0,"LongTermDebtNoncurrent_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":12744000.0,"EarningsPerShareDiluted_1_Q2_USD":0.1,"EarningsPerShareDiluted_2_Q2_USD":0.17,"LiabilitiesAndStockholdersEquity_0_Q2_USD":556218000.0,"PreferredStockValue_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":268047000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":24400000.0,"InventoryNet_0_Q2_USD":68350000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":6130000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":5363000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":8228000.0,"OperatingIncomeLoss_1_Q2_USD":6014000.0,"OperatingIncomeLoss_2_Q2_USD":10535000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":796000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q2_USD":-142000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2_Q2_USD":-210000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q2_USD":26349000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5622000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2604000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":2526000.0,"CommonStockSharesOutstanding_0_Q2_shares":34132106.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-2203000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-19588000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":77169000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":2428000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":6130000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1967000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":4700000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10946000.0,"StockholdersEquity_0_Q2_USD":417827000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":370000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":17829000.0,"SalesTypeAndDirectFinancingLeasesProfitLoss_2_Q2_USD":-3000.0,"OperatingExpenses_1_Q2_USD":60387000.0,"OperatingExpenses_2_Q2_USD":122353000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":10741000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5853000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":54338000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":141000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":28289000.0,"Ticker":"NTUS","CIK":"878526","name":"NATUS MEDICAL INC","OfficialName":"Natus Medical Incorporated Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1152673159.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]